AAAAAA

   
Results: 1-25 | 26-33
Results: 1-25/33
RELATION OF FREE PSA TOTAL PSA IN SERUM FOR DIFFERENTIATING BETWEEN PATIENTS WITH PROSTATIC-CANCER AND BENIGN HYPERPLASIA OF THE PROSTATE -WHICH CUTOFF SHOULD BE USED
Authors: LEIN M STEPHAN C JUNG K SCHNORR D LOENING S
Citation: M. Lein et al., RELATION OF FREE PSA TOTAL PSA IN SERUM FOR DIFFERENTIATING BETWEEN PATIENTS WITH PROSTATIC-CANCER AND BENIGN HYPERPLASIA OF THE PROSTATE -WHICH CUTOFF SHOULD BE USED, Cancer investigation, 16(1), 1998, pp. 45-49
PLASMA-CONCENTRATIONS OF METALLOPROTEINASES (MMP-1, MMP-3) AND THEIR INHIBITORS IN PATIENTS WITH PROSTATE-CANCER
Authors: LEIN M NOWAK L JUNG K KOENIG F SCHNORR D LOENING SA
Citation: M. Lein et al., PLASMA-CONCENTRATIONS OF METALLOPROTEINASES (MMP-1, MMP-3) AND THEIR INHIBITORS IN PATIENTS WITH PROSTATE-CANCER, Der Urologe, 37(4), 1998, pp. 377-381
QUANTIFICATION OF MATRIX METALLOPROTEINASES AND TISSUE INHIBITORS OF METALLOPROTEINASE IN PROSTATIC TISSUE - ANALYTICAL ASPECTS
Authors: JUNG K LEIN M ULBRICH N RUDOLPH B HENKE W SCHNORR D LOENING SA
Citation: K. Jung et al., QUANTIFICATION OF MATRIX METALLOPROTEINASES AND TISSUE INHIBITORS OF METALLOPROTEINASE IN PROSTATIC TISSUE - ANALYTICAL ASPECTS, The Prostate, 34(2), 1998, pp. 130-136
CATHEPSIN-B, CATHEPSIN-H, CATHEPSIN-L AND CYSTEINE PROTEINASE-INHIBITORS IN RENAL-CELL CARCINOMA - NO EVIDENCE FOR DYSREGULATED PROTEOLYTICBALANCE
Authors: JUNG K FRIEDRICH B TURK I ROIGAS J LEIN M SCHNORR D LOENING SA
Citation: K. Jung et al., CATHEPSIN-B, CATHEPSIN-H, CATHEPSIN-L AND CYSTEINE PROTEINASE-INHIBITORS IN RENAL-CELL CARCINOMA - NO EVIDENCE FOR DYSREGULATED PROTEOLYTICBALANCE, Journal of cancer research and clinical oncology, 124(1), 1998, pp. 60-61
CONFOCAL LASER-SCANNING MICROSCOPY OF BLADDER TISSUE IN-VIVO
Authors: KOENIG F GONZALEZ S WHITE MW LEIN M RAJADHYAKSHA M
Citation: F. Koenig et al., CONFOCAL LASER-SCANNING MICROSCOPY OF BLADDER TISSUE IN-VIVO, The Journal of urology, 159(5), 1998, pp. 339-339
RATIO OF FREE-TO-TOTAL PROSTATE-SPECIFIC ANTIGEN IN SERUM CANNOT DISTINGUISH PATIENTS WITH PROSTATE-CANCER FROM THOSE WITH CHRONIC INFLAMMATION OF THE PROSTATE
Authors: JUNG K MEYER A LEIN M RUDOLPH B SCHNORR D LOENING SA
Citation: K. Jung et al., RATIO OF FREE-TO-TOTAL PROSTATE-SPECIFIC ANTIGEN IN SERUM CANNOT DISTINGUISH PATIENTS WITH PROSTATE-CANCER FROM THOSE WITH CHRONIC INFLAMMATION OF THE PROSTATE, The Journal of urology, 159(5), 1998, pp. 1595-1598
MATRIX METALLOPROTEINASE-2 IN BLOOD DOES NOT INDICATE THE PROGRESSIONOF PROSTATE-CANCER
Authors: JUNG K LAUBE C LEIN M TURK I LICHTINGHAGEN R RUDOLPH B SCHNORR D LOENING SA
Citation: K. Jung et al., MATRIX METALLOPROTEINASE-2 IN BLOOD DOES NOT INDICATE THE PROGRESSIONOF PROSTATE-CANCER, International journal of cancer, 78(3), 1998, pp. 392-393
KIND OF SAMPLE AS PREANALYTICAL DETERMINANT OF MATRIX METALLOPROTEINASE-2 AND METALLOPROTEINASE-9 AND TISSUE INHIBITOR OF METALLOPROTEINASE-2 IN BLOOD
Authors: JUNG K LAUBE C LEIN M LICHTINGHAGEN R TSCHESCHE H SCHNORR D LOENING SA
Citation: K. Jung et al., KIND OF SAMPLE AS PREANALYTICAL DETERMINANT OF MATRIX METALLOPROTEINASE-2 AND METALLOPROTEINASE-9 AND TISSUE INHIBITOR OF METALLOPROTEINASE-2 IN BLOOD, Clinical chemistry, 44(5), 1998, pp. 1060-1062
THE PERCENTAGE OF FREE PROSTATE-SPECIFIC ANTIGEN IS AN AGE-INDEPENDENT TUMOR-MARKER FOR PROSTATE-CANCER - ESTABLISHMENT OF REFERENCE RANGESIN A LARGE POPULATION OF HEALTHY-MEN
Authors: LEIN M KOENIG F JUNG K MCGOVERN FJ SKATES SJ SCHNORR D LOENING SA
Citation: M. Lein et al., THE PERCENTAGE OF FREE PROSTATE-SPECIFIC ANTIGEN IS AN AGE-INDEPENDENT TUMOR-MARKER FOR PROSTATE-CANCER - ESTABLISHMENT OF REFERENCE RANGESIN A LARGE POPULATION OF HEALTHY-MEN, British Journal of Urology, 82(2), 1998, pp. 231-236
ELIMINATION OF SERUM-FREE AND TOTAL PROSTATE-SPECIFIC ANTIGEN AFTER RADICAL RETROPUBIC PROSTATECTOMY
Authors: LEIN M BRUX B JUNG K HENKE W KOENIG F STEPHAN C SCHNORR D LOENING SA
Citation: M. Lein et al., ELIMINATION OF SERUM-FREE AND TOTAL PROSTATE-SPECIFIC ANTIGEN AFTER RADICAL RETROPUBIC PROSTATECTOMY, European journal of clinical chemistry and clinical biochemistry, 35(8), 1997, pp. 591-595
ANTIOXIDANT ENZYMES IN MALIGNANT PROSTATE CELL-LINES AND IN PRIMARY CULTURED PROSTATIC CELLS
Authors: JUNG K SEIDEL B RUDOLPH B LEIN M CRONAUER MV HENKE W HAMPEL G SCHNORR D LOENING SA
Citation: K. Jung et al., ANTIOXIDANT ENZYMES IN MALIGNANT PROSTATE CELL-LINES AND IN PRIMARY CULTURED PROSTATIC CELLS, Free radical biology & medicine, 23(1), 1997, pp. 127-133
SOLUBLE CD44 VARIANTS IN THE SERUM OF PATIENTS WITH UROLOGICAL MALIGNANCIES
Authors: LEIN M JUNG K WEISS S SCHNORR D LOENING SA
Citation: M. Lein et al., SOLUBLE CD44 VARIANTS IN THE SERUM OF PATIENTS WITH UROLOGICAL MALIGNANCIES, Oncology, 54(3), 1997, pp. 226-230
CAN PROSTATE-SPECIFIC ANTIGEN DERIVATIVES REDUCE THE FREQUENCY OF UNNECESSARY PROSTATE BIOPSIES
Authors: STEPHAN C LEIN M JUNG K SCHNORR D LOENING SA
Citation: C. Stephan et al., CAN PROSTATE-SPECIFIC ANTIGEN DERIVATIVES REDUCE THE FREQUENCY OF UNNECESSARY PROSTATE BIOPSIES, The Journal of urology, 157(4), 1997, pp. 1371-1371
FACTORS INFLUENCING THE RATIO OF FREE TO TOTAL PROSTATE-SPECIFIC ANTIGEN IN SERUM
Authors: MEYER A JUNG K LEIN M RUDOLPH B SCHNORR D LOENING SA
Citation: A. Meyer et al., FACTORS INFLUENCING THE RATIO OF FREE TO TOTAL PROSTATE-SPECIFIC ANTIGEN IN SERUM, International journal of cancer, 74(6), 1997, pp. 630-636
MATRIX METALLOPROTEINASE-1 AND MATRIX METALLOPROTEINASE-3, TISSUE INHIBITOR OF METALLOPROTEINASE-1 AND THE COMPLEX OF METALLOPROTEINASE-1 TISSUE INHIBITOR IN PLASMA OF PATIENTS WITH PROSTATE-CANCER
Authors: JUNG K NOWAK L LEIN M PRIEM F SCHNORR D LOENING SA
Citation: K. Jung et al., MATRIX METALLOPROTEINASE-1 AND MATRIX METALLOPROTEINASE-3, TISSUE INHIBITOR OF METALLOPROTEINASE-1 AND THE COMPLEX OF METALLOPROTEINASE-1 TISSUE INHIBITOR IN PLASMA OF PATIENTS WITH PROSTATE-CANCER, International journal of cancer, 74(2), 1997, pp. 220-223
INCREASED ANALYTICAL SENSITIVITY OF RT-PCR OF PSA MESSENGER-RNA DECREASES DIAGNOSTIC SPECIFICITY OF DETECTION OF PROSTATIC CELLS IN BLOOD
Authors: HENKE W JUNG M JUNG K LEIN M SCHLECHTE H BERNDT C RUDOLPH B SCHNORR D LOENING SA
Citation: W. Henke et al., INCREASED ANALYTICAL SENSITIVITY OF RT-PCR OF PSA MESSENGER-RNA DECREASES DIAGNOSTIC SPECIFICITY OF DETECTION OF PROSTATIC CELLS IN BLOOD, International journal of cancer, 70(1), 1997, pp. 52-56
ANALYTICAL ASPECTS REGARDING THE MEASUREMENT OF METALLOPROTEINASES AND THEIR INHIBITORS IN BLOOD
Authors: LEIN M NOWAK L JUNG K KOENIG F LICHTINGHAGEN R SCHNORR D LOENING SA
Citation: M. Lein et al., ANALYTICAL ASPECTS REGARDING THE MEASUREMENT OF METALLOPROTEINASES AND THEIR INHIBITORS IN BLOOD, Clinical biochemistry, 30(6), 1997, pp. 491-496
THE INFLUENCE OF PROSTATE VOLUME ON THE RATIO OF FREE TO TOTAL PROSTATE-SPECIFIC ANTIGEN IN SERUM OF PATIENTS WITH PROSTATE CARCINOMA AND BENIGN PROSTATE HYPERPLASIA
Authors: STEPHAN C LEIN M JUNG K SCHNORR D LOENING SA
Citation: C. Stephan et al., THE INFLUENCE OF PROSTATE VOLUME ON THE RATIO OF FREE TO TOTAL PROSTATE-SPECIFIC ANTIGEN IN SERUM OF PATIENTS WITH PROSTATE CARCINOMA AND BENIGN PROSTATE HYPERPLASIA, Cancer, 79(1), 1997, pp. 104-109
RATIO OF FREE-PSA TOTAL-PSA - AN INDICATO R FOR DIFFERENTIATION BETWEEN PATIENTS WITH PROSTATE-CANCER AND BENIGN PROSTATIC HYPERPLASIA/
Authors: LEIN M STEPHAN C JUNG K KOENIG F SCHNORR D LOENING SA
Citation: M. Lein et al., RATIO OF FREE-PSA TOTAL-PSA - AN INDICATO R FOR DIFFERENTIATION BETWEEN PATIENTS WITH PROSTATE-CANCER AND BENIGN PROSTATIC HYPERPLASIA/, Aktuelle Urologie, 28(6), 1997, pp. 323-328
SOLUBLE CD44 MOLECULES IN SERUM OF PATIENTS WITH PROSTATE-CANCER AND BENIGN PROSTATIC HYPERPLASIA
Authors: JUNG K LEIN M WEISS S SCHNORR D HENKE W LOENING S
Citation: K. Jung et al., SOLUBLE CD44 MOLECULES IN SERUM OF PATIENTS WITH PROSTATE-CANCER AND BENIGN PROSTATIC HYPERPLASIA, European journal of cancer, 32A(4), 1996, pp. 627-630
STRIP TEST FOR THE QUICK DETECTION OF INCREASED CONCENTRATIONS OF PROSTATE-SPECIFIC ANTIGEN IN BLOOD
Authors: LEIN M JUNG K SCHNORR D HENKE W LOENING SA
Citation: M. Lein et al., STRIP TEST FOR THE QUICK DETECTION OF INCREASED CONCENTRATIONS OF PROSTATE-SPECIFIC ANTIGEN IN BLOOD, European journal of clinical chemistry and clinical biochemistry, 34(6), 1996, pp. 511-514
SOLUBLE CD44 VARIANTS IN SERUM OF PATIENTS WITH PROSTATE-CANCER AND OTHER UROLOGICAL MALIGNANCIES
Authors: LEIN M WEISS S JUNG K SCHNORR D LOENING S
Citation: M. Lein et al., SOLUBLE CD44 VARIANTS IN SERUM OF PATIENTS WITH PROSTATE-CANCER AND OTHER UROLOGICAL MALIGNANCIES, The Prostate, 29(5), 1996, pp. 334-335
ISOFORMS OF PROSTATE-SPECIFIC ANTIGEN IN SERUM - A RESULT OF THE GLYCOSYLATION PROCESS IN DYSPLASTIC PROSTATIC CELLS
Authors: JUNG K LEIN M HENKE W SCHNORR D LOENING SA
Citation: K. Jung et al., ISOFORMS OF PROSTATE-SPECIFIC ANTIGEN IN SERUM - A RESULT OF THE GLYCOSYLATION PROCESS IN DYSPLASTIC PROSTATIC CELLS, The Prostate, 29(1), 1996, pp. 65-66
THE PHARMACOLOGICAL EFFECT OF THE GONADOTROPIN-RELEASING-HORMONE ON EXPERIMENTAL CRYPTORCHIDISM IN RATS
Authors: LEIN M FAHLENKAMP D SCHONBERGER B PROLLIUS S LOENING S
Citation: M. Lein et al., THE PHARMACOLOGICAL EFFECT OF THE GONADOTROPIN-RELEASING-HORMONE ON EXPERIMENTAL CRYPTORCHIDISM IN RATS, Scandinavian journal of urology and nephrology, 30(3), 1996, pp. 185-191
THE RATIO OF FREE TO TOTAL PROSTATE-SPECIFIC ANTIGEN IN SERUM IS CORRELATED TO THE PROSTATE VOLUME
Authors: STEPHAN C JUNG K LEIN M SCHNORR D LOENING SA
Citation: C. Stephan et al., THE RATIO OF FREE TO TOTAL PROSTATE-SPECIFIC ANTIGEN IN SERUM IS CORRELATED TO THE PROSTATE VOLUME, International journal of cancer, 67(3), 1996, pp. 461-462
Risultati: 1-25 | 26-33